Vaxcyte COO sells 3,477 shares under 10b5-1
PCVX’s chief operating officer exercised options and sold shares under a Rule 10b5-1 plan, with additional shares withheld to cover RSU tax obligations.
Rhea-AI Filing Summary
Vaxcyte, Inc. (PCVX) chief operating officer Jim Wassil reported an option exercise and related share transactions. On September 1, 2026 he exercised 2,250 stock options at $5.35 per share into common stock, then sold 3,477 shares around $61 per share in open-market transactions under a Rule 10b5-1 trading plan. On August 31 and September 2, 2026, a total of 2,705 shares of common stock were withheld or surrendered at prices near $61 solely to cover tax liabilities from vesting RSUs. Following the exercise, Wassil held 66,648 stock options of the same series directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
8 txns
Insider
Wassil Jim
Role
CHIEF OPERATING OFFICER
Sold
3,477 shs ($212K)
Approx. gross sale proceeds
$212K
Approx. exercise cost
$12K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1 | 1,432 | $61.58 | $88K |
| Exercise | Stock Option (right to buy) F7 | 2,250 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,250 | $5.35 | $12K |
| Sale | Common Stock F2, F3 | 1,537 | $60.886 | $94K |
| Sale | Common Stock F2, F4 | 713 | $61.481 | $44K |
| Sale | Common Stock F2, F5 | 924 | $60.955 | $56K |
| Sale | Common Stock F2, F6 | 303 | $61.424 | $19K |
| Tax Withholding | Common Stock F1 | 1,273 | $60.74 | $77K |
Holdings After Transaction:
Stock Option (right to buy) — 66,648 contracts (Direct);
Common Stock — 153,609 shares (Direct)
Footnotes (7)
- F1. Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
- F3. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7. Stock Option is fully vested and exercisable.
Key Figures
Shares sold: 3,477 shares
Sale prices: $60.886, $61.481, $60.955, $61.424 per share
Options exercised: 2,250 shares
+5 more
8 metrics
Shares sold
3,477 shares
Common stock sales on September 1, 2026
Sale prices
$60.886, $61.481, $60.955, $61.424 per share
Weighted-average prices for multiple sale lots on September 1, 2026
Options exercised
2,250 shares
Stock options exercised into common stock on September 1, 2026
Option exercise price
$5.35 per share
Exercise price for 2,250 stock options expiring April 17, 2030
Options held after transaction
66,648 options
Directly held stock options of the same series following the exercise
Shares for tax withholding
2,705 shares
Shares surrendered or withheld to cover RSU tax liabilities on August 31 and September 2, 2026
RSU tax-withholding prices
$60.74 and $61.58 per share
Per-share prices for tax-withholding dispositions on August 31 and September 2, 2026
Rule 10b5-1 plan adoption date
December 9, 2025
Date the trading plan governing the reported sales was adopted
Key Terms
Rule 10b5-1 trading plan, Restricted Stock Units, weighted-average price, stock option
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted Stock Units financial
"tax withholding obligations realized upon the vesting of RSUs"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted-average price financial
"The price reported is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
stock option financial
"Stock Option is fully vested and exercisable."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did PCVX executive Jim Wassil report in this Form 4?
He reported exercising 2,250 stock options at $5.35 per share into common stock, selling 3,477 shares around $61 per share, and having 2,705 shares withheld or surrendered to cover RSU-related tax liabilities.
What stock options did the PCVX COO exercise in this filing?
Jim Wassil exercised 2,250 stock options with an exercise price of $5.35 per share, expiring on April 17, 2030. After the transaction, he directly held 66,648 stock options of the same series.
AI-generated analysis. How Rhea-AI works. Not financial advice.
